Recurrence and Progression of Head and Neck Paragangliomas after Treatment
Authors:
- 18 February 2020
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 162 (4) , 504-511
Abstract
Objective: To characterize the recurrence of head and neck paragangliomas and the factors associated with disease progression after treatment.Study Design: Retrospective cohort study.Setting: Tertiary care center.Subjects and Methods: In total, 173 adults with 189 paragangliomas (41.3% carotid body, 29.1% glomus jugulare, 19.0% glomus tympanicum, and 10.6% glomus vagale) treated between 1990 and 2010 were evaluated to determine the incidence and risk of recurrence using Cox proportional hazards.Results: The mean (SD) follow‐up duration was 8.6 (9.1) years. The incidence was 2.92 recurrences per 100 person‐years. The rate of recurrence was 8.2% (95% confidence interval [CI], 3.7‐12.7) after 4 years and 17.1% (95% CI, 10.2‐24.0) after 10 years. Glomus jugulare tumors were more likely to recur (hazard ratio [HR], 3.69; 95% CI, 1.70‐8.01; P <. 001) while carotid body tumors were less likely (HR, 0.44; 95% CI, 0.21‐0.97; P =. 041). Radiation had a lower risk of recurrence or progression compared to surgical excision (HR, 0.30; 95% CI, 0.10‐.94; P =. 040). Recurrence was associated with right‐sided paragangliomas (HR, 3.60; 95% CI, 1.63‐7.75; P =. 001). The median time to recurrence was 18.4 years. Six (3.2%) patients developed metastasis, which was more common with local recurrence (9.5% vs 1.4%, P =. 015).Conclusions: Recurrence is more common with glomus jugulare tumors and less common with carotid body tumors. Radiation may have a lower risk of recurrence or progression than surgery for some paraganglioma types. Metastasis is rare but more likely with recurrent disease. Surveillance neck imaging is recommended every several years for decades after treatment.Keywords
This publication has 46 references indexed in Scilit:
- Imaging Work-Up for Screening of Paraganglioma and Pheochromocytoma inSDHxMutation Carriers: A Multicenter Prospective Study from the PGL.EVA InvestigatorsThe Journal of Clinical Endocrinology & Metabolism, 2013
- An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary SyndromesHormone and Metabolic Research, 2012
- Head and neck paragangliomas: Report of 175 patients (1989–2010)Head & Neck, 2011
- Metastatic ParagangliomaSeminars in Oncology, 2010
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Complication Rates After Left- Versus Right-Sided Carotid EndarterectomyCirculation: Cardiovascular Quality and Outcomes, 2009
- Management of head and neck paragangliomas: Review of 120 patientsHead & Neck, 2009
- Definitive radiotherapy in the management of paragangliomas arising in the head and neck: A 35‐year experienceHead & Neck, 2008
- The genetics of paragangliomas: a reviewClinical Otolaryngology, 2007
- National Cancer Data Base report on malignant paragangliomas of the head and neckCancer, 2002